As part of our series focussing on available products in Australia, we have added a product review of use of N-Terminal pro-Brain Natriuretic Peptide for the detection of pulmonary arterial hypertension in systemic sclerosis.
This review discusses screening for SSc-PAH, current guidelines, quantification of NT-proBNP in practice and a series of clinical studies. It also provides commentary from Dr Wendy Stevens, a Consultant Rheumatologist at St Vincent’s Hospital, Melbourne.
Please login below to download this issue (PDF)